Recipient
Intellijoint Surgical Inc.Department
National Research Council CanadaAmount
$550.0K
Province
ONType
Contribution
Agreement Number
172-2025-2026-Q2-1033993
Purpose
The OEM business model (IJX) is a strategic priority for Intellijoint Surgical to increase revenue growth, better leverage costs and diversify the business. At this time IJX has a small but growing customer base. This project seeks to drive faster revenue growth and customer acquisition by investments into the core technology platform to maximize the portability, scalability and differentiation of IJX solutions.
Intellijoint Surgical Inc. × National Research Council Canada
17 grants totalling $2.1M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $112.4M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |